Today's Date
Grass Pollen Immunotherapy plus Dupilumab for Tolerance Induction
(
GRADUATE
)
ITN Protocol #:
ITN084AD
Branded Name:
GRADUATE
Treatment Protocol #:
Therapeutic Area:
Allergy & Asthma
Current Status:
Follow-up
Summary:
A Randomized, Double-blind, Single-center, Placebo-controlled Study of Antigen-specific Sublingual immunotherapy plus Dupilumab for Induction of Tolerance in Adults with Seasonal Allergic RhinitisGrass Immunotherapy plus Dupilumab for Tolerance Evaluation
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Rho Scientist
Study Personnel:
